Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.
Google Scholar
Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70:1–25.
Google Scholar
Machanahalli Balakrishna A, Ismayl M, Srinivasamurthy R, Gowda RM, Aboeata A. Early outcomes of percutaneous coronary intervention in patients with cancer: a systematic review and meta-analysis. Curr Probl Cardiol. 2022;47:101305.
Google Scholar
Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2024;149:e347–e913.
Google Scholar
Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R, Kueh MTW, et al. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol. 2024;32:1001–15.
Doolub G, Mamas MA. Percutaneous coronary angioplasty in patients with cancer: clinical challenges and management strategies. J Pers Med. 2022;12:1372.
Google Scholar
Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomark Prev. 2016;25:1029–36.
Google Scholar
Nobre Menezes M, Mamas MA. PCI in Cancer patients: adding another piece to a complex and still very incomplete puzzle. Circ Cardiovasc Interv. 2024;17:e014076.
Google Scholar
Zöller B, Ji J, Sundquist J, Sundquist K. Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012;48:121–8.
Google Scholar
Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133:1104–14.
Google Scholar
Wilcox NS, Amit U, Reibel JB, Berlin E, Howell K, Ky B. Cardiovascular disease and cancer: shared risk factors and mechanisms. Nat Rev Cardiol. 2024;21:617–3.
Google Scholar
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860.
Google Scholar
Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83:456S–60S.
Google Scholar
Lorusso R, Vizzardi E, Johnson DM, Mariscalco G, Sciatti E, Maessen J, et al. Cardiac surgery in adult patients with remitted or active malignancies: a review of preoperative screening, surgical management and short- and long-term postoperative results. Eur J Cardiothorac Surg. 2018;54:10–8.
Google Scholar
Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40:3889–97.
Google Scholar
Mamas MA, Brown SA, Sun LY. Coronary artery disease in patients with cancer: it’s always the small pieces that make the bigger picture. Mayo Clin Proc. 2020;95:1819–21.
Google Scholar
Belzile-Dugas E, Eisenberg MJ. Radiation-induced cardiovascular disease: review of an underrecognized pathology. J Am Heart Assoc. 2021;10:e021686.
Google Scholar
Floyd JD, Nguyen DT, Lobins RL, Bashir Q, Doll DC, Perry MC. Cardiotoxicity of cancer therapy. J Clin Oncol. 2005;23:7685–96.
Google Scholar
Herrmann J, Yang EH, Iliescu CA, Cilingiroglu M, Charitakis K, Hakeem A, et al. Vascular toxicities of cancer therapies: the old and the new–an evolving avenue. Circulation. 2016;133:1272–89.
Google Scholar
Landes U, Kornowski R, Bental T, Assali A, Vaknin-Assa H, Lev E, et al. Long-term outcomes after percutaneous coronary interventions in cancer survivors. Coron Artery Dis. 2017;28:5–10.
Google Scholar
Tabata N, Sueta D, Yamamoto E, Takashio S, Arima Y, Araki S, et al. Outcome of current and history of cancer on the risk of cardiovascular events following percutaneous coronary intervention: a Kumamoto University Malignancy and Atherosclerosis (KUMA) study. Eur Heart J Qual Care Clin Outcomes. 2018;4:290–300.
Google Scholar
Leong DP, Cirne F, Aghel N, Baro Vila RC, Cavalli GD, Ellis PM, et al. Cardiac interventions in patients with active, advanced solid and hematologic malignancies: JACC: cardiooncology state-of-the-art review. JACC CardioOncol. 2023;5:415–30.
Google Scholar
Potts JE, Iliescu CA, Lopez Mattei JC, Martinez SC, Holmvang L, Ludman P, et al. Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States. Eur Heart J. 2018;40:1790–800.
Devereaux PJ, Lamy A, Chan MTV, Allard RV, Lomivorotov VV, Landoni G, et al. High-sensitivity troponin I after cardiac surgery and 30-day mortality. N Engl J Med. 2022;386:827–36.
Google Scholar
Portefaix H, Papin G, Kantor E, Iung B, Montravers P, Longrois D, et al. One-year outcome after cardiac surgery for patients with cancer: an observational monocentric retrospective study. J Cardiothorac Vasc Anesth. 2022;36:1934–41.
Google Scholar
Braile DM, Evora PRB. Cardiopulmonary bypass and cancer dissemination: a logical but unlikely association. Braz J Cardiovasc Surg. 2018;33:I–II.
Google Scholar
Pinto CA, Marcella S, August DA, Holland B, Kostis JB, Demissie K. Cardiopulmonary bypass has a modest association with cancer progression: a retrospective cohort study. BMC Cancer. 2013;13:519.
Google Scholar
Mistiaen WP, Van Cauwelaert P, Muylaert P, Wuyts F, Harrisson F, Bortier H. Effect of prior malignancy on survival after cardiac surgery. Ann Thorac Surg. 2004;77:1593–7.
Google Scholar
Chan J, Rosenfeldt F, Chaudhuri K, Marasco S. Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality. Heart Lung Circ. 2012;21:255–9.
Google Scholar
Sun LY, Gaudino M, Chen RJ, Bader Eddeen A, Ruel M. Long-term outcomes in patients with severely reduced left ventricular ejection fraction undergoing percutaneous coronary intervention vs coronary artery bypass grafting. JAMA Cardiol. 2020;5:631–41.
Google Scholar
Sun LY, Rodger J, Duffett L, Tulloch H, Crean AM, Chong AY, et al. Derivation of patient-defined adverse cardiovascular and noncardiovascular events through a modified Delphi process. JAMA Netw Open. 2021;4:e2032095.
Google Scholar
Sun LY, Jabagi H, Fang J, Lee DS. Comparison of multidimensional frailty instruments for estimation of long-term patient-centered outcomes after cardiac surgery. JAMA Netw Open. 2022;5:e2230959.
Google Scholar
RID SCfPHS. https://redivis.com/datasets/96hs-egqe74693?v=3.12024.
Sciences SCfPH. 2020. https://redivis.com/datasets/jv2x-25dm36err?v=3.12024.
Karamnov S, Brovman EY, Greco KJ, Urman RD. Risk factors and outcomes associated with sepsis after coronary artery bypass and open heart valve surgeries. Semin Cardiothorac Vasc Anesth. 2018;22:359–68.
Google Scholar
Dyas AR, Bronsert MR, Henderson WG, Stuart CM, Pradhan N, Colborn KL, et al. A comparison of the National Surgical Quality Improvement Program and the Society of Thoracic Surgery Cardiac Surgery preoperative risk models: a cohort study. Int J Surg. 2023;109:2334–43.
Google Scholar
Shah AM, Almomani AA, Sako EY, Hui DS. Surgical and transcatheter mitral valve therapy: medicare utilization and reimbursement. Ann Thorac Surg. 2024;118:164–71.
Google Scholar
Brovman EY, Kuo C, Lekowski RW, Urman RD. Outcomes after transcatheter aortic valve replacement: a propensity matched retrospective cohort study. J Cardiothorac Vasc Anesth. 2018;32:2169–75.
Google Scholar
Ho VT, Itoga NK, Tran K, Lee JT, Stern JR. Mid-term survival after thoracic endovascular aortic repair by indication in the medicare population. J Am Coll Surg. 2021;232:46–53 e2.
Google Scholar
Chiu P, Goldstone AB, Schaffer JM, Lingala B, Miller DC, Mitchell RS, et al. Endovascular versus open repair of intact descending thoracic aortic aneurysms. J Am Coll Cardiol. 2019;73:643–51.
Google Scholar
Scali ST, Goodney PP, Walsh DB, Travis LL, Nolan BW, Goodman DC, et al. National trends and regional variation of open and endovascular repair of thoracic and thoracoabdominal aneurysms in contemporary practice. J Vasc Surg. 2011;53:1499–505.
Google Scholar
Fielding-Singh V, Vanneman MW, Hong T, Sun LY, Morris AM, Chertow GM, et al. Association of kidney function with inpatient mortality and morbidity after cardiac surgery. Ann Thorac Surg Short Rep. 2024;2:877–83.
Carter JB, Johnson MM, Chua TL, Karia PS, Schmults CD. Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. JAMA Dermatol. 2013;149:35–42.
Google Scholar
Cheng J, Yan S. Prognostic variables in high-risk cutaneous squamous cell carcinoma: a review. J Cutan Pathol. 2016;43:994–1004.
Google Scholar
AHRQ PSI Technical Documentation, Version v2024, Agency for Healthcare Research and Quality, Rockville, MD. https://qualityindicators.ahrq.gov/measures/PSI_TechSpec. Accessed 9 Aug 2024.
Zhou S, Zhang Y, Dong X, Zhang X, Ma J, Li N, et al. Sex disparities in management and outcomes among patients with acute coronary syndrome. JAMA Netw Open. 2023;6:e2338707.
Google Scholar
Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.
Google Scholar
Elixhauser 2024. https://hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/comorbidity_icd10.jsp.
Ullah W, DiMeglio M, Frisch DR, Bagur R, Sun LY, Fischman DL, et al. Outcomes and discriminatory accuracy of the CHA(2)DS(2)VASc score in atrial fibrillation and cancer. JACC Adv. 2023;2:100609.
Google Scholar
Gilbert T, Neuburger J, Kraindler J, Keeble E, Smith P, Ariti C, et al. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet. 2018;391:1775–82.
Google Scholar
Fielding-Singh V, Vanneman MW, Grogan T, Neelankavil JP, Winkelmayer WC, Chang TI, et al. Association between preoperative hemodialysis timing and postoperative mortality in patients with end-stage kidney disease. JAMA. 2022;328:1837–48.
Google Scholar
Zheng J, Heidenreich PA, Kohsaka S, Fearon WF, Sandhu AT. Long-term outcomes of early coronary artery disease testing after new-onset heart failure. Circ Heart Fail. 2023;16:e010426.
Google Scholar
Tu K, Wang M, Young J, Green D, Ivers NM, Butt D, et al. Validity of administrative data for identifying patients who have had a stroke or transient ischemic attack using EMRALD as a reference standard. Can J Cardiol. 2013;29:1388–94.
Google Scholar
Centers for Medicare and Medicaid Services. Billing and coding: percutaneous coronary intervention, Version v2023. Baltimore, MD. 2024. Accessed 9 Aug 2024.
Yun H, Kilgore ML, Curtis JR, Delzell E, Gary LC, Saag KG, et al. Identifying types of nursing facility stays using medicare claims data: an algorithm and validation. Health Serv Outcomes Res Method. 2010;10:100–10.
Google Scholar
Goodwin JS, Li S, Zhou J, Graham JE, Karmarkar A, Ottenbacher K. Comparison of methods to identify long term care nursing home residence with administrative data. BMC Health Serv Res. 2017;17:376.
Google Scholar
Sullivan DR, Kim H, Gozalo PL, Bunker J, Teno JM. Trends in noninvasive and invasive mechanical ventilation among medicare beneficiaries at the end of life. JAMA Intern Med. 2021;181:93–102.
Google Scholar
Guha A, Dey AK, Omer S, Abraham WT, Attizzani G, Jneid H, et al. Contemporary trends and outcomes of percutaneous and surgical mitral valve replacement or repair in patients with cancer. Am J Cardiol. 2020;125:1355–60.
Google Scholar
Carrascal Y, Gualis J, Arévalo A, Fulquet E, Flórez S, Rey J, et al. Cardiac surgery with extracorporeal circulation in cancer patients: influence on surgical morbidity and mortality and on survival. Rev Esp Cardiol. 2008;61:369–75.
Google Scholar
Forster RB, Kjellstadli C, Myklebust T, Egeland G, Sulo G, Bjørge T, et al. Treatment and 30-day mortality after myocardial infarction in prostate cancer patients: a population-based study from Norway. Cardiology. 2023;148:83–92.
Google Scholar
Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation. 2004;109:3122–31.
Google Scholar
Staab J, Cotter E, Kidd B, Wallisch WJ, Flynn BC. Review and update: hematologic malignancies and adult cardiac surgery. J Cardiothorac Vasc Anesth. 2020;34:759–71.
Google Scholar
Nardi P, Pellegrino A, Pugliese M, Bovio E, Chiariello L, Ruvolo G. Cardiac surgery with extracorporeal circulation and concomitant malignancy: early and long-term results. J Cardiovasc Med. 2016;17:152–9.
Google Scholar
Eagle KA, Ginsburg GS, Musunuru K, Aird WC, Balaban RS, Bennett SK, et al. Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. Circulation. 2010;121:1447–54.
Google Scholar
Garatti A, D’Ovidio M, Saitto G, Daprati A, Canziani A, Mossuto E, et al. Coronary artery bypass grafting in patients with concomitant solid tumours: early and long-term results. Eur J Cardiothorac Surg. 2020;58:528–36.
Google Scholar
Hayek SS, Ganatra S, Lenneman C, Scherrer-Crosbie M, Leja M, Lenihan DJ, et al. Preparing the cardiovascular workforce to care for oncology patients. J Am Coll Cardiol. 2019;73:2226–35.
Google Scholar
Barac A, Murtagh G, Carver JR, Chen MH, Freeman AM, Herrmann J, et al. Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J Am Coll Cardiol. 2015;65:2739–46.
Google Scholar
Sommer S-P, Lange V, Yildirim C, Schimmer C, Aleksic I, Wagner C, et al. Cardiac surgery and hematologic malignancies: a retrospective single-center analysis of 56 consecutive patients. Eur J Cardiothorac Surg. 2011;40:173–8.
Google Scholar
Zhang M-K, Zhang H-W, Wu Q-Y, Xue H, Fan L-X. Coronary artery bypass grafting in patients with malignancy: a single-institute case series of eight patients. BMC Surg. 2022;22:359.
Google Scholar
Aboumsallem JP, Moslehi J, de Boer RA. Reverse cardio-oncology: cancer development in patients with cardiovascular disease. J Am Heart Assoc. 2020;9:e013754.
Google Scholar
Bell Caitlin F, Lei X, Haas A, Baylis Richard A, Gao H, Luo L, et al. Risk of cancer after diagnosis of cardiovascular disease. JACC CardioOncol. 2023;5:431–40.
Google Scholar
Cornwell LD, Omer S, Rosengart T, Holman WL, Bakaeen FG. Changes over time in risk profiles of patients who undergo coronary artery bypass graft surgery: the Veterans Affairs Surgical Quality Improvement Program (VASQIP). JAMA Surg. 2015;150:308–15.
Google Scholar
Prins C, de Villiers Jonker I, Botes L, Smit FE. Cardiac surgery risk-stratification models. Cardiovasc J Afr. 2012;23:160–4.
Google Scholar
Bonelli A, Lorusso R, Paris S, Troise G, Mohammed AH, Bursi F, et al. Active cancer and cardiac surgery: Possible scenarios in patient decision-making. Monaldi Arch Chest Dis. 2021;91:1–9.
Madrigal J, Tran Z, Hadaya J, Sanaiha Y, Benharash P. Impact of chronic lymphocytic leukemia on outcomes and readmissions after cardiac operations. Ann Thorac Surg. 2022;114:152–9.
Google Scholar
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12–49.
Google Scholar
Guler A, Sahin MA, Cingoz F, Ozal E, Demirkilic U, Arslan M. Can cardiac surgery be performed safely on patients with haematological malignancies. Cardiovasc J Afr. 2012;23:194–6.
Google Scholar
Fecher AM, Birdas TJ, Haybron D, Papasavas PK, Evers D, Caushaj PF. Cardiac operations in patients with hematologic malignancies. Eur J Cardiothorac Surg. 2004;25:537–40.
Google Scholar
Noguchi M, Tabata M, Ito J, Kato N, Obunai K, Watanabe H, et al. Midterm outcomes of transcatheter aortic valve replacement in patients with active cancer. Open Heart. 2024;11:e002573.
Google Scholar
Li R, Luo Q, Huddleston SJ. Patients with metastatic cancer have worse short-term coronary artery bypass grafting outcomes: a population-based study of National Inpatient Sample from 2015 to 2020. Cardiovasc Revasc Med. 2024;69:62–7.
Google Scholar
Andres M, Murphy TM, Poku N, Nazir S, Ramalingam S, Chambers V, et al. Cardio-Oncology: a medical specialty in constant growth and evolution. the 10-year experience of the first cardio-oncology service in the United Kingdom. Eur Heart J. 2022;43:ehac544-2564.
Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40:87–165.
Google Scholar
Wahba A, Kunst G, De Somer F, Kildahl HA, Milne B, Kjellberg G, et al. 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery. Br J Anaesth. 2025;134:917–1008.
Google Scholar
Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023;82:833–955.
Google Scholar
